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ABSTRACT
Methods: Human dental pulp cells were cultured for 5 days in Minimum Essential Medium Alpha (α-MEM) complete containing amphotericin 
B, penicillin, streptomycin, and fetal bovine serum. Then, the treatment group was exposed to crab shell chitosan RGD scaffold membrane and 
crab shell chitosan scaffold membrane incubated for 24 h. The toxicity of the crab shell chitosan RGD scaffold membrane was analyzed with a 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay.
Result: The result of this research is that crab shell chitosan RGD scaffold membrane did not decrease the percentage of viability of human dental 
pulp cells.
Conclusion: It is concluded that crab shell chitosan RGD scaffold membrane does not have toxic effects on human dental pulp cells.
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INTRODUCTION
Bone defects can happen due to trauma, periodontal disease, tumors, 
cysts, and congenital abnormalities, leading to conditions that can 
change a patient’s quality of life [1]. There are a variety of treatments 
available to cure these conditions.
One such treatment is the use of a bone graft. Bone grafts can be 
obtained from patients themselves (autograft) or from other animal 
species (xenograft). Bone grafts have been used for many years and are 
considered a standard treatment for bone defects; however, autografts 
show some disadvantages such as insufficient supply and donor site 
pain [1]. These disadvantages lead to the development of alternative 
technologies such as tissue engineering. Tissue engineering is a 
technique that is used for repairing or generating new tissue and consists 
of three main components: Growth factor, stem cells, and scaffold 
(Amir et al.). Growth factor is a transcription factor that originates from 
gene activation during the tissue engineering process [2]. Stem cells are 
unspecialized cells that have a high proliferation rate and can generate 
complex tissues and organs [3]. Stem cells can originate from dental 
pulp [4]. A scaffold is a temporary, extracellular matrix that facilitates 
cell attachment, cell proliferation, and cell differentiation [5].
One material that can be used as a scaffold is chitosan, the biopolymer 
derivative of chitin that can be obtained from the exoskeleton of 
crustaceans such as crab and shrimp. It is biocompatible, biodegradable, 
and has osteoinductive abilities [6]. However, chitosan lacks bioactive 
signals that are important for cell attachment, proliferation, and 
differentiation. For this reason, a chitosan scaffold is often modified 
with some bioactive molecules such as arginine-glycine-aspartic acid 
(RGD).
RGD is a cell adhesion peptide that can be found in extracellular 
matrix proteins such as laminin and collagen. The objective of 
adding RGD to a chitosan scaffold is to improve cell attachment to 
the scaffold. Nowadays, Badan Tenaga Nuklir Nasional (BATAN) 
develops crab shell chitosan RGD scaffold in the form of a membrane 
combined with RGD. The purpose of forming this scaffold into a 
membrane is to obtain a scaffold that has high stability when used to 
repair bone defects, especially large bone defects. However, before 
this scaffold can be used in tissue engineering, studies must ensure 
that this scaffold is biocompatible, meaning that this scaffold is non-
toxic. The objective of this study is to analyze the toxicity of crab 
shell chitosan RGD scaffold membrane on human dental pulp cell 
viability.
METHODS
In this research, crab shell chitosan RGD scaffold produced by BATAN, 
Indonesia, was used. The scaffold had the following specifications: In 
membrane form (2.5 cm × 1 cm); in white color; degree of deacetylation 
was 94.5%; viscosity 34.40 cps; and 4 mg RGD/50 ml chitosan 2%. 
The scaffold was produced using a freeze-drying method (Fig. 1). The 
toxicity of crab shell chitosan RGD scaffold membrane on the viability of 
human dental pulp cells was analyzed with a 3-(4,5-dimethythiazol-2-
yl)-2,5-diphenyl tetrazolium bromide (MTT) test. Two kinds of chitosan 
materials were used: Crab shell chitosan RGD scaffold membrane 
and crab shell chitosan scaffold membrane without RGD. Crab shell 
chitosan RGD scaffold membranes with 1 mg and 2 mg concentration, 
were described in human dental pulp cell cultures and incubated for 
24 h. Human dental pulp cell viability was expressed as a percent of the 
control. Test difference between groups was then analyzed using the 
one-way analysis of variance test (ANOVA test).
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arginylglycylaspartic acid (RGD) scaffold membrane. The purpose of adding RGD was to enhance cell attachment to the scaffold.
The objective of this research is to analyze the toxicity of crab shell chitosan RGD scaffold membrane on human dental pulp cells and its effect on 
their viability.
International workshop on Dental Research hosted by Faculty of Dentistry Universitas Indonesia, Jakarta, 2017 148 
Int J App Pharm, Vol 9, Special Issue 2, 2017
 Dewi et al. 
Cell culture
First premolar or impacted third molars were removed from patients 
at the Dental Hospital, Faculty of Dentistry, Universitas Indonesia. 
The human teeth were soaked in Minimum Essential Medium Alpha 
(α-MEM) complete. Every 50 ml of α-MEM complete contains of 
L-glutamine, ribonucleosides and deoxyribonucleosides with 10% 
fetal bovine serum, penicillin 10.000 IU/ml, streptomycin 100 mg, 
and amphotericin B 25 μg/ml. Furthermore, the teeth were washed 
with phosphate buffer saline containing antibiotics. Dental pulp tissue 
was obtained using an extirpation needle and collected on a petri dish 
containing α-MEM without serum. Human dental pulp cells (106) were 
cultured in a 25 cm2 flask with α-MEM complete for up to 5 days. The 
medium was replaced every 2 days.
MTT
Toxicity tests were analyzed using MTT. The MTT assay is used as an 
indirect measure of cell toxicity based on the number of living cells left 
after being exposed to a test material. Human dental pulp cells, with 
a density of 2 ×104, were placed on a 96-well plate and cultured for 
5 days. With the aim of advancing cell growth, the medium was replaced 
every 2 days. Next, the treatment group was presented with the crab 
shell chitosan RGD scaffold membrane with and without RGD (1 mg and 
2 mg). A 96-well plate was incubated in a CO2 incubator (37°C, 5% CO2) 
for 24 h. After incubation, an MTT test was conducted by adding 15 ml 
solution of MTT (5 mg/ml) to all test groups.
Further, incubation in a CO2 incubator (37°C, 5% CO2) was conducted for 
3 h. Next, 100 µl of acidified isopropanol was added to each well, followed 
by incubation at room temperature for 1 h on an orbital shaker to dissolve 
the formazan crystals. Samples absorbance values (OD) were read using 
an enzyme-linked immunosorbent assay reader with a wavelength of 
490 nm. Data were corrected with a culture medium without cells (blank 
value). The experiment was repeated twice on each test group that was 
at least Duplo. Cell viability was calculated using the following formula:
Cell viability = (mean absorbance value treatment group)/(average 
value of absorbance of control group) ×100%
Statistical Analysis
The data were presented as mean values and standard deviations. First, 
the data were tested using a Shapiro-Wilk normality test. Significant 
differences in the data were analyzed using a one-way ANOVA test 
(p<0.05).
RESULT
Effect of rotary cell culture system on human dental pulp cells
Human dental pulp cells used in this study were cultured for 5 days 
(Fig. 2).
Based on one-way ANOVA statistical analyses, there were significant 
differences in cell viability between the control group and all chitosan-
treated groups.
The viability of human dental pulp cells markedly increased after 
exposure to crab shell chitosan RGD scaffold membrane compared to 
the control group.
Based on one-way ANOVA statistical analyses, there was a significant 
difference in cell viability between the crab shell chitosan RGD scaffold 
membrane 1 mg treated group and the crab shell chitosan scaffold 
membrane 1 mg treated group (p<0.05) and between the crab shell 
Fig. 1: Crab shell chitosan arginylglycylaspartic acid scaffold
Fig. 2: Microscope image of human dental pulp cell, cultured for 5 
days with magnification ×10
Fig. 4: Optical density value of 3-(4,5-dimethythiazol-2-yl)-2,5-
diphenyl tetrazolium bromide assay between four chitosan-
treated groups (error bars show standard deviation; *p < 0.05)
Fig. 3: Optical density value of 3-(4,5-dimethythiazol-2-yl)-2,5-
diphenyl tetrazolium bromide assay between control group and 
all chitosan-treated groups (error bars show standard deviation; 
*p < 0.05)
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chitosan RGD scaffold membrane 2 mg treated group and the crab shell 
chitosan scaffold membrane 2 mg treated group (p<0.05).
In larger bone defects, especially one-wall periodontitis defects, the use 
of bone grafts is ineffective due to disadvantages such as immunology 
effects that can happen after transplantation [1]. Three decades ago, 
tissue engineering was developed as an alternative technique to treat 
larger bone defect [7]. Tissue engineering consists of three major 
components: Scaffold, stem cells, and growth factor. A material that 
can be used as a scaffold in bone tissue engineering is chitosan. It is 
biocompatible, biodegradable, and non-toxic. However, to increase 
chitosan’s efficacy, chitosan needs to be combined with a bioactive 
molecule such as RGD. A previous study reported that a chitosan scaffold 
combined with RGD could enhance the attachment and proliferation of 
osteoblasts in vitro.
In this research, crab shell chitosan RGD scaffold membrane and crab 
shell chitosan scaffold membrane produced by BATAN, Indonesia, and 
human dental pulp cells were used. Toxicity analyses were conducted 
using the MTT assay method. Based on this research, it was determined 
that crab shell chitosan RGD scaffold membranes did not decrease the 
cell viability of human dental pulp cells. This result was supported 
by other research using chitosan scaffolds with and without RGD. 
A preliminary study also showed that the proliferation of human dental 
pulp did not decrease after being exposed to a crab shell chitosan RGD 
scaffold membrane.
To identify a dose-effect relationship, we used crab shell chitosan scaffold 
membranes with or without RGD in two different concentrations, 1 mg 
and 2 mg. As seen in Fig. 4, there is no significant difference in cell 
viability between the crab shell chitosan RGD scaffold membrane 1 mg 
treated group and the crab shell chitosan RGD scaffold membrane 2 mg 
treated group and between the crab shell chitosan scaffold membrane 
1 mg treated group and the crab shell chitosan scaffold membrane 2 mg 
treated group.
Fig. 4 also shows that the viability of human dental pulp cells (%) 
treated with the crab shell chitosan scaffold membrane 1 mg treated 
group was significantly higher than the dental pulp cells treated with 
the crab shell chitosan RGD scaffold membrane 1 mg treated group. Like 
the 1 mg concentration conditions, the viability of human dental pulp 
cells (%) treated with the crab shell chitosan scaffold membrane 2 mg 
treated group was also higher than the dental pulp cells treated with 
the crab shell chitosan RGD scaffold membrane 1 mg treated group. 
Based on a statistical analysis using a one-way ANOVA, the difference 
was significant.
These results are in agreement with the preliminary study that used crab 
shell chitosan scaffold membrane and crab shell chitosan RGD scaffold 
membrane 1 mg and 2 mg, indicating that the level of cell proliferation 
of the human dental pulp cells was higher in the crab shell chitosan 
scaffold 1 mg group. Based on the data above, the viability percentage 
of human dental pulp cell treated with crab shell chitosan scaffold 
membrane without RGD was higher than the viability percentage of 
human dental pulp cell treated with crab shell chitosan RGD scaffold 
membrane. This result cannot be explained because only two samples 
were used in this study, which does not allow for the exploration of a 
dose and effect relationship.
In clinical applications, membrane scaffolds coat all damaged bone 
surfaces to transfer nutrients for the cells to achieve localized tissue 
repair. The addition of RGD to crab shell chitosan scaffold membranes 
is used to enhance cell attachment to the scaffold along with obtaining 
a good adhesion to the network. Cell adhesion is the first stage before 
cells can proliferate. This study shows that the addition of RGD to the 
crab shell chitosan RGD scaffold membrane did not have toxic effects 
on human dental pulp cells. In future studies, relations between effects 
and doses need to be determined to obtain optimal cell numbers and 
chitosan scaffold membrane levels. When scaffolds and implanted cells 
are transplanted to areas of  bone damage, based on results on these 
types of studies, cell proliferation and cell differentiation can be ideal.
CONCLUSION
This study showed that the addition of RGD to the crab shell chitosan 
membrane did not have toxic effects on human dental pulp cells. Crab 
shell chitosan RGD scaffold membrane and crab shell chitosan scaffold 
membrane showed different effects on human dental pulp cells.
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